AMS Capital’s CME Group CME Stock Holding History

AMS Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-38,980	Closed	-$9.27M	–	21
2022 Q1	$9.27M	Buy	+38,980	New	+$9.15M	3.5%	11

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AMS Capital's CME Position: Q2 2022 in Review

AMS Capital sold out of CME Group (CME) in Q2 2022, closing a stake of 38,980 shares — an estimated $9.27M sold.

AMS Capital first reported a position in CME in Q1 2022 and held it in 1 quarter. The position peaked at $9.27M in Q1 2022. 1,158 funds tracked by Wall St. Rank hold CME as of Q2 2022.

AMS Capital reported no remaining CME Group position as of Q2 2022 after selling out during the quarter.
AMS Capital sold 38,980 CME Group shares in Q2 2022, an estimated $9.27M.
AMS Capital first reported a position in CME Group in Q1 2022 and held it in 1 quarter.
AMS Capital's CME Group position peaked at $9.27M in Q1 2022.
1,158 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on AMS Capital's 13F filing for Q2 2022, filed 4 Aug 2022.